0001687423-16-000002.txt : 20161025 0001687423-16-000002.hdr.sgml : 20161025 20161025162220 ACCESSION NUMBER: 0001687423-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161025 DATE AS OF CHANGE: 20161025 EFFECTIVENESS DATE: 20161025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: M Pharmaceutical Inc. CENTRAL INDEX KEY: 0001687423 IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-273189 FILM NUMBER: 161950608 BUSINESS ADDRESS: STREET 1: 734-1055 DUNSMUIR STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1B1 BUSINESS PHONE: 604-428-0511 MAIL ADDRESS: STREET 1: 734-1055 DUNSMUIR STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1B1 D 1 primary_doc.xml X0707 D LIVE 0001687423 M Pharmaceutical Inc. 734-1055 DUNSMUIR STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V7X 1B1 604-428-0511 ALBERTA, CANADA First Sahara Energy Inc. None Corporation true George Tsfalas 734-1055 Dunsmuir Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1B1 Director Christopher Andrews 414-16A Street NW Calgary A0 ALBERTA, CANADA T2N 2C8 Director Rick Skeith 216 Edelweiss Drive NE Calgary A0 ALBERTA, CANADA T3A 4A3 Director Brian D. Keane 13 Quintree Lane Melville NY NEW YORK 11747 Executive Officer Tatiana Kovalena 734-1055 Dunsmuir Street Vancouver A1 BRITISH COLUMBIA, CANADA V7X 1B1 Executive Officer Gary Thompson 4030 Mt. Carmel Road Suite 327D Cincinnati OH OHIO 45255 Executive Officer Pharmaceuticals No Revenues 06b false 2016-09-07 false true true true false 0 25832 25832 0 444,140 units were sold to US subscribers at C$0.075, a total amount of C$33,310.50. The rate of exchange of the C$, based on the noon buying rate as reported by the Federal Reserve Bank of New York on the date of the first sale, was C$1.00=US$0.7755. false 5 0 0 400000 true These proceeds will be used to pay executive officer and director salaries, and to pay legal fees to the Company's law firm, where one of the Company's directors is a senior partner. false M Pharmaceutical Inc. Rick Skeith Rick Skeith Director 2016-10-18